Company Filing History:
Years Active: 2004-2013
Title: Innovations by Inventor Claudio Dalvit in Milan, Italy
Introduction
Claudio Dalvit is an eminent inventor located in Milan, Italy, known for his contributions to the field of pharmaceutical sciences. With a portfolio of 4 patents, Dalvit has made significant strides through his innovative work, particularly in the development of compounds that have the potential to treat serious medical conditions.
Latest Patents
Dalvit's latest patents include groundbreaking inventions that focus on [1,2,4]triazolo[1,5-c]pyrimidine derivatives, which act as modulators of Heat Shock Protein Hsp90. These compounds are particularly valuable in the treatment of proliferative diseases such as cancer and neurodegenerative disorders. The invention outlines not only the structure of these derivatives but also provides methods for their preparation, therapeutic applications, and pharmaceutical compositions containing these compounds. His approach is aimed at inhibiting the activity of Hsp90, a critical player in cellular stress responses.
Another innovative patent involves a method of identifying a ligand to a target molecule. This method includes the use of nuclear magnetic resonance spectroscopy to determine interactions between a reference compound and various test compounds. By comparing resonance patterns, Dalvit’s technique allows for the identification of test compounds that effectively interact with target molecules, thereby advancing drug discovery efforts.
Career Highlights
Throughout his career, Claudio Dalvit has worked with notable companies, including Nerviano Medical Sciences and Pharmacia & Upjohn Company. His experience in these organizations has provided him with a solid foundation for the innovative research he conducts today. His patents reflect a deep understanding of pharmaceutical chemistry and a commitment to improving therapeutic options for critical health conditions.
Collaborations
Dalvit has collaborated with skilled professionals, including Brian J. Stockman and Kathleen A. Farley, who share his passion for scientific discovery and innovation. Their collaborative efforts have contributed to advancing research initiatives and enhancing the development of novel therapies within the pharmaceutical industry.
Conclusion
Claudio Dalvit continues to be a pivotal figure in the realm of pharmaceutical inventions. With his innovative patents and collaborative spirit, he exemplifies the attributes of a dedicated inventor committed to improving human health. His work not only contributes valuable knowledge to the science of drug development but also holds promise for patients suffering from serious diseases worldwide.